124 related articles for article (PubMed ID: 33844466)
1. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.
Erbilgin Y; Hatirnaz Ng O; Can I; Firtina S; Kucukcankurt F; Karaman S; Karakas Z; Celkan TT; Zengin E; Aylan Gelen S; Nihal Ozdemir G; Yildirmak Y; Dogru O; Tansel T; Khodzhaev K; Toluk O; Ozbek U; Sayitoglu M
Int J Lab Hematol; 2021 Oct; 43(5):1093-1103. PubMed ID: 33844466
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
3. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
4. [Mutation and expression of LEF1 in adult acute lymphocytic leukemia and their clinical significance].
Liu J; Guo X; Ge Z; Zhang R; Xu JY; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1212-6. PubMed ID: 25338559
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia.
Kühnl A; Gökbuget N; Kaiser M; Schlee C; Stroux A; Burmeister T; Mochmann LH; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood; 2011 Dec; 118(24):6362-7. PubMed ID: 22010100
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.
Fu Y; Zhu H; Wu W; Xu J; Chen T; Xu B; Qian S; Li J; Liu P
Leuk Lymphoma; 2014 Feb; 55(2):371-7. PubMed ID: 23713453
[TBL] [Abstract][Full Text] [Related]
7. High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.
Metzeler KH; Heilmeier B; Edmaier KE; Rawat VP; Dufour A; Döhner K; Feuring-Buske M; Braess J; Spiekermann K; Büchner T; Sauerland MC; Döhner H; Hiddemann W; Bohlander SK; Schlenk RF; Bullinger L; Buske C
Blood; 2012 Sep; 120(10):2118-26. PubMed ID: 22815426
[TBL] [Abstract][Full Text] [Related]
8. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.
Albano F; Zagaria A; Anelli L; Orsini P; Minervini CF; Impera L; Casieri P; Coccaro N; Tota G; Brunetti C; Minervini A; Pastore D; Carluccio P; Mestice A; Cellamare A; Specchia G
Oncotarget; 2014 Feb; 5(3):649-58. PubMed ID: 24378360
[TBL] [Abstract][Full Text] [Related]
10. [A study of LEF1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
[No Abstract] [Full Text] [Related]
11. Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in
Carr T; McGregor S; Dias S; Verykokakis M; Le Beau MM; Xue HH; Sigvardsson M; Bartom ET; Kee BL
Front Immunol; 2022; 13():845488. PubMed ID: 35371057
[TBL] [Abstract][Full Text] [Related]
12. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
[TBL] [Abstract][Full Text] [Related]
13.
Sırma Ekmekci S; Emrence Z; Abacı N; Sarıman M; Salman B; Ekmekci CG; Güleç Ç
Turk J Haematol; 2020 Nov; 37(4):226-233. PubMed ID: 32586085
[TBL] [Abstract][Full Text] [Related]
14. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.
Gutierrez A; Sanda T; Ma W; Zhang J; Grebliunaite R; Dahlberg S; Neuberg D; Protopopov A; Winter SS; Larson RS; Borowitz MJ; Silverman LB; Chin L; Hunger SP; Jamieson C; Sallan SE; Look AT
Blood; 2010 Apr; 115(14):2845-51. PubMed ID: 20124220
[TBL] [Abstract][Full Text] [Related]
16. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
17. Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Ruan ZP; Tian T; Guo H; Wang SH; Nan KJ
Dis Markers; 2013; 35(5):395-405. PubMed ID: 24223455
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
